NN
Nicholson Nur
Chief Technical Officer
OFFICER
Historial del iniciado
DirectivoTodavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Explore the detailed record of transactions filed by Nicholson Nur, Chief Technical Officer. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 22 disclosures have been published. Split: 0 buy · 10 sells. Total volume traded: €1.1m. History available since 21 January 2022. The latest transaction was filed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Nicholson Nur
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones22 en total
116.338 títulosCommon StockSEC:0001193125-26-224604:0
45.220 títulos0Common StockSEC:0001492422-26-000074:0
7725 títulos@ 21,7654 US$9.5% de su flujoCommon StockSEC:0001492422-26-000056:0
2203 títulos@ 19,7929 US$2.5% de su flujoCommon StockSEC:0001492422-26-000040:0
2618 títulos@ 22,1872 US$3.3% de su flujoCommon StockSEC:0001492422-26-000027:0
825 títulos@ 29,5236 US$1.8% de su flujoCommon StockSEC:0001127602-25-002383:0
3948 títulos@ 30,4255 US$9.0% de su flujoCommon StockSEC:0001127602-25-001841:0
2145 títulos@ 29,9582 US$4.9% de su flujoCommon StockSEC:0001127602-25-001625:0
36.426 títulos0Common StockSEC:0001127602-25-001625:1
2632 títulos@ 28,7021 US$5.8% de su flujoCommon StockSEC:0001127602-25-001201:0
7768 títulos@ 57,307 US$31.8% de su flujoCommon StockSEC:0001127602-24-010127:0
835 títulos@ 64,1382 US$3.9% de su flujoCommon StockSEC:0001127602-24-002746:0
2593 títulos@ 64,996 US$12.1% de su flujoCommon StockSEC:0001127602-24-001953:0
19.508 títulos0Common StockSEC:0001127602-24-001437:0
9719 títulos@ 29,76 US$68.5% de su flujoCommon StockSEC:0001127602-23-024445:0
9886 títulos0Common StockSEC:0000899243-23-005786:0
551 títulos@ 52,77 US$2.1% de su flujoCommon StockSEC:0001127602-23-002687:0
2034 títulos@ 52,05 US$7.6% de su flujoCommon StockSEC:0001127602-23-002133:0
1875 títulos0Common StockSEC:0001127602-23-001499:0
22.580 títulos0Common StockSEC:0001127602-23-001499:1
650 títulos@ 38,59 US$0.0004% mcap50.0% de su flujoCommon StockSEC:0001127602-22-002812:0
26.051 títulos0Common StockSEC:0001127602-22-002062:0
About Nicholson Nur
Nicholson Nur is Chief Technical Officer at Apellis Pharmaceuticals, Inc. (XNAS). He has 22 filings in total, and in the sampled recent filings all transactions are sales, for a total amount of EUR 1,117,681 between 2022-01-25 and 2026-05-14.